Creative Medical Technology Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Creative Medical Technology Holdings, Inc. (CELZ) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $35.67 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2022-03-30
- Creative Medical Technology Holdings, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2021 was $35.67K, a 0.00% change from fiscal 2020.
- Creative Medical Technology Holdings, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2020 was $35.67K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2021-12-31 | $35.67K 10-K · filed 2022-03-30 |
| 2020-12-31 | $35.67K 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |